Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending April 12, 2020 PCA3 test as a noninvasive diagnostic biomarker of prostate cancer, mCRPC: Bone scan index is a valuable prognostic indicator, Higher risk of prostate cancer in patients with melanoma, Altered levels of trace elements in patients with prostate cancer, Localized prostate cancer: Similar long-term outcomes with moderate and conventional hypofractionation, More must reads Must reads for theWeek ending March 29, 2020 Statin, metformin lower mortality in high-risk prostate cancer , Surgery improves survival in localized prostate cancer, Higher incidence of second primary malignancy in metastatic castration-resistant prostate cancer, Localized prostate cancer: Low- and favorable intermediate-risk groups may benefit from single dose HDR brachytherapy, Advanced prostate cancer: Extended androgen suppression lowers risk of distant progression, regardless of radiation dose , More must readsMust reads for theWeek ending March 22, 2020 PSA levels predict survival in high-grade prostate cancer , HSD3B1 genotype linked to poorer survival in metastatic prostate cancer, New mHSPC: Addition of cixutumumab to androgen deprivation has no survival benefit, Spironolactone use linked to lower prostate cancer risk, Prostate cancer: High risk patients derive direct survival advantage from extended PLND, More must readsMust reads for theWeek ending March 1, 2020 Localized Prostate Cancer: Adjuvant Chemotherapy Prolongs PFS in Some High-Risk Patients, Prostate Cancer: Salvage Focal Cryotherapy Feasible and Effective, Extended Pelvic Lymph Node Dissection Predicts Rehospitalization After Robot-Assisted Radical Prostatectomy, Active Surveillance Safe in Low-Grade Prostate Cancer Over Long Term, Localized Prostate Cancer: Very High Initial PSA Tied to Poorer Oncological Outcomes After Radical Prostatectomy, More must readsMust reads for theWeek ending February 9, 2020 Docetaxel Improves Survival Outcomes for Prostate Cancer, Regardless of Metastatic Burden, Alpha-Emitting Radioisotopes Improve Survival in Metastatic Castration-Resistant Prostate Cancer, Olaparib Shows Activity in Prostate Cancer With DRR Mutations, High Incidence of Inguinal Hernia After Prostate Cancer Surgery, Kidney Transplantation Does Not Increase the Risk of Prostate Cancer, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 last »
